Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Replimune Group Inc (NASDAQ: REPL) closed at $9.45 in the last session, down -3.08% from day before closing price of $9.75. In other words, the price has decreased by -$3.08 from its previous closing price. On the day, 1.27 million shares were traded.
Ratios:
We take a closer look at REPL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.95 and its Current Ratio is at 7.95. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
On August 28, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $17.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Astley-Sparke Philip sold 32,279 shares for $8.06 per share. The transaction valued at 260,169 led to the insider holds 1,405,071 shares of the business.
Xynos Konstantinos sold 7,952 shares of REPL for $64,093 on May 20 ’25. The Chief Medical Officer now owns 146,933 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Schwendenman Andrew, who serves as the Chief Accounting Officer of the company, sold 3,287 shares for $8.05 each. As a result, the insider received 26,460 and left with 68,284 shares of the company.
Stock Price History:
Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $6.44. The 50-Day Moving Average of the stock is 6.34%, while the 200-Day Moving Average is calculated to be -14.76%.
Shares Statistics:
A total of 77.09M shares are outstanding, with a floating share count of 62.53M. Insiders hold about 18.88% of the company’s shares, while institutions hold 94.55% stake in the company.
